Eradication of Hepatitis C Virus 1b by Interferon in a Health Care Worker with Acute Hepatitis following Needlestick Transmission from a Patient with Chronic Hepatitis C Unresponsive to Interferon

References

• Kiyosawa K, Sodeyama T, Tanaka E, Nakano Y, Furuta S, Nishioka K, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 1991;115:367–9.
   PubMed Web of Science ®Google Scholar
• Puro V, Petrosillo N, Ippolito G, Aloisi MS, Boumis E, Rava L, et al. Occupational hepatitis C virus infection in Italian health care workers. Am J Public Health 1995;85:1272–5.
   PubMedGoogle Scholar
• Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, van Nest G, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994;91:1294–8.
   PubMed Web of Science ®Google Scholar
• Schiff ER. Hepatitis C among health care providers: risk factors and possible prophylaxis. Hepatology 1992;16:1300–1.
   PubMedGoogle Scholar
• Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers. An application to clinical surveys and tracing infection sources. J Gen Virol 1992;73:673–9.
   Google Scholar
• Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321–4.
   PubMed Web of Science ®Google Scholar
• Doglio A, Laffont C, Caroli-Bosc FX, Rochet P, Lefebvre J. Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant. J Clin Microbiol 1999;37:1567–9.
   Google Scholar
• Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two- stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60: 215–22.
   PubMedGoogle Scholar
• Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990;87:9524–8.
   PubMed Web of Science ®Google Scholar
• Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77–81.
   PubMed Web of Science ®Google Scholar
• Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991;338:914–5.
   PubMed Web of Science ®Google Scholar
• Ohnishi K, Nomura F, Nakano M. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 1991; 86:1041–9.
   Google Scholar
• Viladomiu L, Genesca J, Esteban JI, Allende H, Gonzalez A, Lopez-Talavera LC, et al. Interferon-α in acute posttransfusion hepatitis C: a randomized, controlled trial. Hepatology 1992;15: 767–9.
   Google Scholar
• Tassopoulos NC, Koutelou MG, Papatheodoridis G, Polychronaki H, Delladetsima I, Giannikakis T, et al. Recombinant human interferon alpha-2b treatment for acute non-A, non-B hepatitis. Gut 1993;34 Suppl:130–2.
   Google Scholar
• Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Coop Study Group. Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Gastroenterology 1994;107:805–11.
   Google Scholar
• Lampertico P, Rumi M, Romeo R, Craxi A, Soffredini R, Biassioni D, et al. A multicenter randomized controlled trial of recombinant interferon α-2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994;19:19–22.
   PubMedGoogle Scholar
• Hwang S-J, Lee S-D, Chan C-Y, Lu R-H, Lo K-J. A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 1994;21: 831–6.
   Google Scholar
• Palmovic D, Kurelac I, Crnjakovic-Palmovic J. The treatment of acute post-transfusion hepatitis C with recombinant interferonalpha. Infection 1994;22:222–3.
   Google Scholar
• Camma C, Almasio P, Craxi A. Interferon as treatment for acute hepatitis C: a meta-analysis. Dig Dis Sci 1996;41:1248–55.
   Google Scholar
• Quin JW. Interferon therapy for acute hepatitis C viral infection—a review by meta-analysis. Aust NZ J Med 1997; 27:611–7.
   PubMedGoogle Scholar
• Poignet J-L, Degos F, Bouchardeau F, Chauveau P, Courouce AM. Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse. J Hepatol 1995; 23:740–1.
   PubMedGoogle Scholar
• Noguchi S, Sata M, Suzuki H, Ohba K, Mizokami M, Tanikawa K. Early therapy with interferon for acute hepatitis C acquired through a needlestick. Clin Infect Dis 1997;24:992–4.
   PubMedGoogle Scholar
• Sakuma I, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C. Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene. J Infect Dis 1999;180:1001–9.
   PubMedGoogle Scholar
• Weiner AJ, Thaler MM, Crawford K, Ching K, Kansopon J, Chien DY, et al. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993;67:4365–8.
   PubMed Web of Science ®Google Scholar
• Tsubota A, Chayama K, Ikeda K, Arase Y, Koida I, Saitoh S, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994;19:1088–94.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-α2a therapy in patients with chronic hepatitis C. Dig Dis Sci 1994; 39:1273–80.
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Higashi Y, Yamada M, Aiyama T, Takayanagi M, Tanaka K, et al. Predictive factors in the response to interferon therapy in chronic hepatitis C. Liver 1995;15:57–62.
   PubMedGoogle Scholar
• Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706–14.
   PubMed Web of Science ®Google Scholar
• Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999;10:439–49.
   PubMed Web of Science ®Google Scholar